cis-4-[4-(2-Methyl-quinolin-4-ylmethoxy)-benzenesulfonylamino]-tetrahydro-pyran-3-carboxylic acid hydroxyamide

ID: ALA4099382

PubChem CID: 11855326

Max Phase: Preclinical

Molecular Formula: C23H25N3O6S

Molecular Weight: 471.54

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cc(COc2ccc(S(=O)(=O)N[C@@H]3CCOC[C@@H]3C(=O)NO)cc2)c2ccccc2n1

Standard InChI:  InChI=1S/C23H25N3O6S/c1-15-12-16(19-4-2-3-5-21(19)24-15)13-32-17-6-8-18(9-7-17)33(29,30)26-22-10-11-31-14-20(22)23(27)25-28/h2-9,12,20,22,26,28H,10-11,13-14H2,1H3,(H,25,27)/t20-,22+/m0/s1

Standard InChI Key:  RGOBJMXLMSLVGN-RBBKRZOGSA-N

Molfile:  

     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   11.9961   -9.3085    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.4128  -10.0252    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   12.8251   -9.3060    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.2698   -9.1877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2686  -10.0150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9834  -10.4279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9816   -8.7749    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.6970   -9.1840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6978  -10.0109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4131  -10.4219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1282  -10.0071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1233   -9.1771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4075   -8.7699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5552   -8.7754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9854  -11.2530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2718  -11.6671    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.5564  -11.2563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5591  -10.4320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8444  -10.0213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1300  -10.4354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1345  -11.2647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8497  -11.6717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7010  -10.4407    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.7040  -11.2657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9899  -11.6744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9910  -12.4959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7052  -12.9096    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.4199  -12.4957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4205  -11.6680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2759  -11.2610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2770  -10.4360    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.5609  -11.6726    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8469  -11.2592    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  4 14  1  0
  6 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 20  2  1  0
  2 23  1  0
 24 23  1  6
 24 25  1  0
 24 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 25 30  1  6
 30 31  2  0
 30 32  1  0
 32 33  1  0
M  END

Associated Targets(Human)

ADAM17 Tchem ADAM17 (3550 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adam17 ADAM17 (101 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 471.54Molecular Weight (Monoisotopic): 471.1464AlogP: 2.31#Rotatable Bonds: 7
Polar Surface Area: 126.85Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 8.82CX Basic pKa: 5.02CX LogP: 1.42CX LogD: 1.40
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.36Np Likeness Score: -1.00

References

1. Ouvry G, Berton Y, Bhurruth-Alcor Y, Bonnary L, Bouix-Peter C, Bouquet K, Bourotte M, Chambon S, Comino C, Deprez B, Duvert D, Duvert G, Hacini-Rachinel F, Harris CS, Luzy AP, Mathieu A, Millois C, Pascau J, Pinto A, Polge G, Reitz A, Reversé K, Rosignoli C, Taquet N, Hennequin LF..  (2017)  Identification of novel TACE inhibitors compatible with topical application.,  27  (8): [PMID:28274635] [10.1016/j.bmcl.2017.02.035]

Source